Current therapeutic approaches in the management of hyperglycemia in chronic renal disease

SGLT2 Inhibitors and the Diabetic Kidney

(2016) Paola Fioretto et al.   DIABETES CARE

One-hour post-load plasma glucose level during the OGTT predicts dysglycemia

(2016) Michael Bergman et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Use of continuous glucose monitoring in patients with diabetes on peritoneal dialysis: poor correlation with HbA1cand high incidence of hypoglycaemia

(2016) E. Oei et al.   DIABETIC MEDICINE

Reasons why patients referred to diabetes education programmes choose not to attend: a systematic review

(2016) G. Horigan et al.   DIABETIC MEDICINE

ANSWERING THE CHALLENGE: PREVENTION OF INPATIENT HYPOGLYCEMIA

(2016) Lillian F. Lien   Endocrine Practice

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM –2016 EXECUTIVE SUMMARY

(2016) Alan J. Garber et al.   Endocrine Practice

Prolactin Promotes Adipose Tissue Fitness and Insulin Sensitivity in Obese Males

(2016) Xarubet Ruiz-Herrera et al.   ENDOCRINOLOGY

Glycated albumin is superior to glycated hemoglobin for glycemic control assessment at an early stage of diabetes treatment: A multicenter, prospective study

(2016) Ju-Ming Lu et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Effects of cabergoline on blood glucose levels in type 2 diabetic patients

(2016) Adele Bahar et al.   MEDICINE

A comparison of two insulin infusion protocols in the medical intensive care unit by continuous glucose monitoring

(2016) Christophe E. M. De Block et al.   Annals of Intensive Care

Sodium-Glucose Linked Cotransporter-2 Inhibition Does Not Attenuate Disease Progression in the Rat Remnant Kidney Model of Chronic Kidney Disease

(2016) Yanling Zhang et al.   PLoS One

The Management of Diabetes Mellitus in Patients with Chronic Kidney Disease: A Population-Based Study in Southern Italy

(2015) Gianluca Trifirò et al.   CLINICAL DRUG INVESTIGATION

Transitioning Safely from Intravenous to Subcutaneous Insulin

(2015) Kathryn Evans Kreider et al.   Current Diabetes Reports

Systematic review and meta-analysis of the efficacy and hypoglycemic safety of gliclazide versus other insulinotropic agents

(2015) Siew Pheng Chan et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes

(2015) Silvio E. Inzucchi et al.   DIABETOLOGIA

Diabetic kidney disease: a clinical update from Kidney Disease: Improving Global Outcomes

(2015) Mark E. Molitch et al.   KIDNEY INTERNATIONAL

Chronic kidney disease and intensive glycemic control increase cardiovascular risk in patients with type 2 diabetes

(2015) Vasilios Papademetriou et al.   KIDNEY INTERNATIONAL

Haemodialysis-induced hypoglycaemia and glycaemic disarrays

(2015) Masanori Abe et al.   Nature Reviews Nephrology

Evaluation and management of diabetic and non-diabetic hypoglycemia in end-stage renal disease

(2015) Aidar R. Gosmanov et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for the Evaluation and Management of CKD

(2014) Lesley A. Inker et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Glycemic Management in ESRD and Earlier Stages of CKD

(2014) Mark E. Williams et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Efficacy and Safety of the Once-Weekly GLP-1 Receptor Agonist Albiglutide Versus Sitagliptin in Patients With Type 2 Diabetes and Renal Impairment: A Randomized Phase III Study

(2014) Lawrence A. Leiter et al.   DIABETES CARE

6. Glycemic Targets

(2014)   DIABETES CARE

Hypoglycemia, Chronic Kidney Disease, and Diabetes Mellitus

(2014) Mazen Alsahli et al.   MAYO CLINIC PROCEEDINGS

Updates on the Management of Diabetes in Dialysis Patients

(2014) Connie M. Rhee et al.   SEMINARS IN DIALYSIS

Basal insulin combined incretin mimetic therapy with glucagon-like protein 1 receptor agonists as an upcoming option in the treatment of type 2 diabetes: a practical guide to decision making

(2014) Gerhard H. Scholz et al.   Therapeutic Advances in Endocrinology and Metabolism

Insulin Degludec: Pharmacokinetics in Patients with Renal Impairment

(2013) István Kiss et al.   CLINICAL PHARMACOKINETICS

Economic Costs of Diabetes in the U.S. in 2012

(2013)   DIABETES CARE

The dipeptidyl peptidase-4 inhibitor alogliptin improves glycemic control in type 2 diabetic patients undergoing hemodialysis

(2013) Yuki Fujii et al.   EXPERT OPINION ON PHARMACOTHERAPY

Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society

(2013) Elizabeth R. Seaquist et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Diabetes Management in the Kidney Patient

(2013) Rajesh Garg et al.   MEDICAL CLINICS OF NORTH AMERICA

Insulin requirements in patients with diabetes and declining kidney function: differences between insulin analogues and human insulin?

(2013) Felix Kulozik et al.   Therapeutic Advances in Endocrinology and Metabolism

KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update

(2012)   AMERICAN JOURNAL OF KIDNEY DISEASES

Glycated Albumin, Not Hemoglobin A1c, Predicts Cardiovascular Hospitalization and Length of Stay in Diabetic Patients on Dialysis

(2012) Mariana Murea et al.   AMERICAN JOURNAL OF NEPHROLOGY

Glycemic Control in Diabetic Dialysis Patients and the Burnt-Out Diabetes Phenomenon

(2012) Jongha Park et al.   Current Diabetes Reports

Hemoglobin A1c Levels and Mortality in the Diabetic Hemodialysis Population: Findings from the Dialysis Outcomes and Practice Patterns Study (DOPPS)

(2012) S. P. B. Ramirez et al.   DIABETES CARE

A Randomized Trial of Two Weight-Based Doses of Insulin Glargine and Glulisine in Hospitalized Subjects With Type 2 Diabetes and Renal Insufficiency

(2012) D. Baldwin et al.   DIABETES CARE

Long-Term Efficacy and Safety of Linagliptin in Patients With Type 2 Diabetes and Severe Renal Impairment: A 1-year, randomized, double-blind, placebo-controlled study

(2012) J. B. McGill et al.   DIABETES CARE

One-year safety, tolerability and efficacy of vildagliptin in patients with type 2 diabetes and moderate or severe renal impairment

(2012) W. Kothny et al.   DIABETES OBESITY & METABOLISM

Defective Counterregulation and Hypoglycemia Unawareness in Diabetes

(2012) Candace M. Reno et al.   ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA

Association Between Glycemic Control and Adverse Outcomes in People With Diabetes Mellitus and Chronic Kidney Disease

(2011) Sabin Shurraw   ARCHIVES OF INTERNAL MEDICINE

Antidiabetic Agents in Patients with Chronic Kidney Disease and End-Stage Renal Disease on Dialysis: Metabolism and Clinical Practice

(2011) Masanori Abe et al.   CURRENT DRUG METABOLISM

Long-term treatment with the dipeptidyl peptidase-4 inhibitor saxagliptin in patients with type 2 diabetes mellitus and renal impairment: a randomised controlled 52-week efficacy and safety study

(2011) M. Nowicki et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Sequence of Cellular Events in Pancreatic Islets Leading to Impaired Insulin Secretion in Chronic Kidney Disease

(2011) Shaul G. Massry   JOURNAL OF RENAL NUTRITION

Glucose handling by the kidney

(2011) Amanda Mather et al.   KIDNEY INTERNATIONAL

Metabolic Acidosis-Induced Insulin Resistance and Cardiovascular Risk

(2011) Gema Souto et al.   Metabolic Syndrome and Related Disorders

Intensive Diabetes Therapy and Glomerular Filtration Rate in Type 1 Diabetes

(2011)   NEW ENGLAND JOURNAL OF MEDICINE

Hemoglobin A1c and Fructosamine for Assessing Glycemic Control in Diabetic Patients With CKD Stages 3 and 4

(2010) Harn-Shen Chen et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Exenatide and renal failure

(2010) J. C. Ferrer-Garcia et al.   DIABETIC MEDICINE

Hypoglycemia in Type 1 Diabetes Mellitus

(2010) Philip E. Cryer   ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA

Severe hyperkalaemia resulting from octreotide use in a haemodialysis patient

(2010) M. Adabala et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

COMPARISON OF GLYCATED ALBUMIN AND HEMOGLOBIN A1c CONCENTRATIONS IN DIABETIC SUBJECTS ON PERITONEAL AND HEMODIALYSIS

(2010) B. I. Freedman et al.   PERITONEAL DIALYSIS INTERNATIONAL

Management of diabetes in dialysis patients

(2009) Mark E. Williams   Current Diabetes Reports

Colesevelam lowers glucose and lipid levels in type 2 diabetes: the clinical evidence

(2009) Vivian A. Fonseca et al.   DIABETES OBESITY & METABOLISM

Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications

(2009) J. E. Gerich   DIABETIC MEDICINE

Rosiglitazone Is Associated with Mortality in Chronic Hemodialysis Patients

(2009) S. P.B. Ramirez et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Evidence for Interindividual Heterogeneity in the Glucose Gradient Across the Human Red Blood Cell Membrane and Its Relationship to Hemoglobin Glycation

(2008) P. K. Khera et al.   DIABETES

Safety and efficacy of sitagliptin in patients with type 2 diabetes and chronic renal insufficiency

(2008) J. C. N. Chan et al.   DIABETES OBESITY & METABOLISM

Effect of Exogenous Intermittent Recombinant Human PTH 1–34 Administration and Chronic Endogenous Parathyroid Hormone Excess on Glucose Homeostasis and Insulin Sensitivity

(2008) A. Anastasilakis et al.   HORMONE AND METABOLIC RESEARCH

Comparison of glycated albumin and hemoglobin A1c levels in diabetic subjects on hemodialysis

(2008) T.P. Peacock et al.   KIDNEY INTERNATIONAL

Na+-Glucose Transporter-2 Messenger Ribonucleic Acid Expression in Kidney of Diabetic Rats Correlates with Glycemic Levels: Involvement of Hepatocyte Nuclear Factor-1α Expression and Activity

(2007) H. S. Freitas et al.   ENDOCRINOLOGY